Testosterone Cypionate and Acne: Why It Happens and How to Manage It
Acne is one of the most common and most visible side effects of testosterone cypionate use. The HAARLEM prospective study found that 52% of steroid users self-reported acne during a cycle, though only 29% had physician-confirmed lesions, suggesting that while acne is frequent, it is often milder than users perceive. The mechanism is straightforward, the risk is dose-dependent, and the management strategies are well established. This guide from Hemi Pharma UK covers why testosterone cypionate causes acne, who is most susceptible, and the evidence-based approach to preventing and treating it at every dose tier.
Key Takeaways
- Testosterone cypionate causes acne through a single pathway: DHT-stimulated sebaceous gland hyperactivity. Testosterone is converted to DHT by 5-alpha reductase in the skin, and DHT binds to androgen receptors in sebocytes, increasing sebum production. Excess sebum clogs pores and creates an environment for Cutibacterium acnes proliferation.
- Acne severity on testosterone cypionate is dose-dependent: 10 to 15% incidence at TRT doses (100 to 200mg/week), 30 to 50% at performance doses (400 to 500mg/week). Individual genetic sensitivity to androgens at the sebaceous gland determines who develops acne and who does not.
- Injection frequency matters: splitting doses lowers peak DHT production, which reduces peak sebaceous stimulation. The same total weekly dose injected twice weekly produces less acne than the same dose injected once weekly in many users.
- First-line management is topical: benzoyl peroxide 2.5% wash on affected areas (back, shoulders, chest), clean bedding, and post-training showers. Second-line is dermatological: low-dose isotretinoin (10 to 20mg daily) under medical supervision for persistent or severe cases.
- Acne from testosterone cypionate is fully reversible after cessation. It typically resolves within 2 to 8 weeks of stopping, though scarring from severe or picked lesions may persist.
Why Does Testosterone Cypionate Cause Acne?
The mechanism is well characterised in dermatology literature. A 2024 review in the Journal of Dermatological Treatment (Del Rosso and Kircik) documented that androgen-mediated excess sebum production is a necessary early step in acne pathophysiology. The sebaceous gland contains both 5-alpha reductase (which converts testosterone to the more potent androgen DHT) and androgen receptors (which respond to DHT by increasing sebocyte proliferation and sebum output). When you inject testosterone cypionate, the elevated serum testosterone provides more substrate for 5-alpha reduction in the skin, producing more local DHT, which drives more sebum.
Excess sebum does three things that collectively produce acne lesions. It physically clogs the follicular opening, creating a microcomedone. It provides a nutrient-rich environment for Cutibacterium acnes (the primary acne-causing bacterium) to proliferate. And it triggers an inflammatory cascade as the immune system responds to the bacterial colonisation and follicular rupture. The result ranges from mild comedonal acne (blackheads and whiteheads) to inflammatory papules and pustules, and in severe cases, nodular or cystic acne that can cause permanent scarring.
A 2025 clinical review of the dermatologic effects of testosterone therapy noted that transdermal testosterone preparations (gels) elevate DHT significantly more than intramuscular injections, which may correlate with higher cutaneous side-effect rates. This is relevant for men switching from NHS gel to testosterone cypionate: despite the higher serum testosterone levels from injection, the DHT-to-testosterone ratio may actually be lower than on gel, potentially producing less acne at equivalent total testosterone exposure.
Who Is Most Susceptible to Acne on Testosterone Cypionate?
| Risk Factor | Why It Increases Acne Risk | Modifiable? |
|---|---|---|
| History of adolescent acne | Indicates genetically androgen-sensitive sebaceous glands | No (genetic) |
| Higher testosterone dose | More substrate for 5-alpha reduction; more DHT; more sebum | Yes (dose guide) |
| Infrequent injection | Higher peaks produce more peak DHT and peak sebaceous stimulation | Yes (increase to twice weekly or EOD) |
| Higher body fat | More aromatase activity; oestradiol fluctuations can affect skin | Yes (weight loss guide) |
| Oily skin type at baseline | Already elevated sebum production before testosterone | Partially (topical management) |
| Stacking with DHT derivatives | Masteron, Winstrol, Proviron add direct DHT-receptor stimulation not blocked by finasteride | Yes (compound selection) |
| Poor skin hygiene | Trapped sebum and bacteria; unchanged bedding; sweat-soaked clothing | Yes (hygiene protocol) |
The most predictive factor is your adolescent acne history. Men who had significant acne during puberty (when endogenous androgen levels first rose) are far more likely to develop acne on testosterone cypionate than men who had clear skin through adolescence. This reflects genetic differences in androgen receptor density and sensitivity within the sebaceous gland, which cannot be changed.
What Does Acne Look Like at Each Testosterone Cypionate Dose?
| Dose | Incidence | Typical Severity | Common Locations | Management Needed |
|---|---|---|---|---|
| 100 to 200mg/week (TRT) | 10 to 15% | Mild: scattered comedones, occasional papules | Face (chin, jawline), upper back | Basic hygiene; benzoyl peroxide if needed |
| 300mg/week | 20 to 30% | Mild to moderate: papules, some pustules | Back, shoulders, chest, face | Benzoyl peroxide wash; salicylic acid; change bedding 2x/week |
| 400 to 500mg/week (cycle) | 30 to 50% | Moderate: widespread papules and pustules; back and shoulders most affected | Back (“bacne”), shoulders, chest, upper arms | Benzoyl peroxide + salicylic acid; consider dermatology referral if severe |
| 600mg+ | 40 to 60%+ | Moderate to severe: nodular or cystic possible in susceptible individuals | Trunk, face, arms | Dermatology referral; low-dose isotretinoin may be needed |
How Do You Prevent and Treat Acne on Testosterone Cypionate?
| Priority | Intervention | How It Works | When to Use |
|---|---|---|---|
| 1 | Increase injection frequency | Lowers peak testosterone and peak DHT; less peak sebaceous stimulation | All users; switch from once weekly to twice weekly minimum |
| 2 | Benzoyl peroxide 2.5% wash | Kills C. acnes bacteria; reduces inflammation; prevents new lesions | Apply to back, shoulders, chest daily; leave on 1 to 2 minutes, rinse |
| 3 | Salicylic acid 2% cleanser | Exfoliates follicular lining; prevents pore clogging | Alternate with benzoyl peroxide or use on face |
| 4 | Shower immediately post-training | Removes sweat, sebum, and bacteria from skin surface | Every training session; do not sit in sweaty clothing |
| 5 | Change bedding twice weekly | Removes accumulated sebum and bacteria from pillowcases and sheets | Ongoing; especially important for facial and upper back acne |
| 6 | Retinoid (adapalene 0.1% gel) | Normalises follicular keratinisation; prevents comedone formation | Available OTC; apply to affected areas nightly; can cause initial purge |
| 7 | Low-dose isotretinoin (10 to 20mg daily) | Reduces sebum production by 70 to 80%; addresses root cause | Prescription only; for moderate to severe acne unresponsive to topicals; requires monitoring (LFTs, lipids) |
Low-dose isotretinoin (10 to 20mg daily, far below the standard acne dose of 0.5 to 1mg/kg) is increasingly used by men on testosterone cypionate who experience persistent moderate acne despite topical management. At these lower doses, the side effects (dry lips, dry skin) are manageable and the sebum-suppressing effect is sufficient to control androgen-driven acne without the severe dryness and potential mental health effects of full-dose isotretinoin. This must be prescribed and monitored by a dermatologist, with liver function and lipid tests every 3 months (note that supraphysiological testosterone already affects lipids, so monitoring is especially important). The blood work guide covers the full panel needed during combined testosterone and isotretinoin use.
Does Finasteride Help with Acne on Testosterone Cypionate?
Since acne is primarily driven by DHT at the sebaceous gland, and finasteride blocks the 5-alpha reductase enzyme that produces DHT, finasteride can reduce acne severity on testosterone cypionate. However, finasteride is not typically prescribed for acne alone: its primary indications are hair loss prevention and benign prostatic hyperplasia. If you are already using finasteride for hair protection, the acne reduction is a welcome secondary benefit. If acne is your only concern, topical management and injection frequency optimisation are more appropriate first-line approaches.
For compounds that are already DHT derivatives (Masteron, Winstrol, Proviron), finasteride does not help because these compounds act directly on the androgen receptor without requiring 5-alpha reduction. If you are stacking testosterone cypionate with one of these and experiencing acne, removing the DHT derivative is more effective than adding finasteride.
When Does Acne Appear and When Does It Resolve on Testosterone Cypionate?
| Timeline | What Happens |
|---|---|
| Weeks 2 to 4 of cycle/TRT | First breakouts appear as serum testosterone and DHT rise; sebaceous glands beginning to respond |
| Weeks 4 to 8 | Acne typically peaks as testosterone reaches steady state and sebum production stabilises at new, higher level |
| Weeks 8 to 12+ | Some users see improvement as the body adapts; others maintain the same severity throughout |
| 2 to 8 weeks after stopping | Acne resolves as testosterone and DHT return to baseline; sebum production normalises |
| Long-term TRT | Initial acne often settles after 3 to 6 months as the body adapts to stable testosterone levels |
The week-by-week timeline covers this alongside other side effect and benefit progressions. For TRT users, the encouraging finding is that acne tends to settle after the initial 3 to 6 month adjustment period as the sebaceous glands adapt to the new, stable hormonal environment. For cycle users, acne is typically a temporary side effect that resolves fully after the cycle ends, provided topical management prevents severe lesions and scarring during the active phase.
Using Hemi Pharma Testosterone Cypionate 200mg with Janoshik-verified dosing ensures your DHT production is predictable and proportional to your intended dose, allowing your acne management strategy to be calibrated accurately.
Frequently Asked Questions
Does testosterone cypionate always cause acne?
No. The HAARLEM study found physician-confirmed acne in 29% of steroid users. At TRT doses, the incidence is 10 to 15%. Many men, particularly those without a history of adolescent acne, use testosterone cypionate without developing any breakouts. Genetic sensitivity of the sebaceous gland androgen receptors is the primary determinant.
Where does testosterone cypionate acne appear?
Most commonly on the back (particularly upper back and shoulders), chest, upper arms, and face (chin and jawline). The back and shoulders have the highest density of sebaceous glands and are most affected at performance doses. Facial acne is more common at TRT doses where the total androgen load is lower.
Will my acne go away after stopping testosterone cypionate?
Yes. Acne from testosterone cypionate is fully reversible and typically resolves within 2 to 8 weeks of stopping as DHT and sebum production return to baseline. Scarring from severe or picked lesions may persist, which is why managing acne actively during the cycle and avoiding squeezing or picking is important.
Is isotretinoin safe to use with testosterone cypionate?
Low-dose isotretinoin (10 to 20mg daily) is used by many men on testosterone cypionate for persistent acne. Both isotretinoin and supraphysiological testosterone can affect lipid profiles, so combined monitoring with liver function and lipid tests every 3 months is essential. This should be prescribed and supervised by a dermatologist.
Does splitting my testosterone cypionate dose reduce acne?
Often yes. Splitting from once weekly to twice weekly injection lowers peak testosterone, which lowers peak DHT production at the sebaceous gland. Many users report noticeable acne improvement after switching to more frequent injection without changing their total weekly dose.
References
Del Rosso, J.Q. and Kircik, L. (2024) ‘The primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance in acne management’, Journal of Dermatological Treatment, 35(1), p. 2296855. Available at: https://pubmed.ncbi.nlm.nih.gov/38146664/ (Accessed: 6 November 2026).
Murphy, J.P. and Rogers, N. (2025) ‘Dermatologic Effects of Testosterone Therapy: A Clinical Review’, LSU Health Sciences Center, New Orleans. Available at: https://www.medschool.lsuhsc.edu/genetics/docs/2025/med_students/Murphy%20Jaclyn%202.pdf (Accessed: 6 November 2026).
Smit, D.L., Buijs, M.M., de Hon, O., den Heijer, M. and de Ronde, W. (2021) ‘Positive and negative side effects of androgen abuse: the HAARLEM study, a one-year prospective cohort study in 100 men’, Scandinavian Journal of Medicine and Science in Sports, 31(2), pp. 427-438. Available at: https://pure.amsterdamumc.nl/en/publications/positive-and-negative-side-effects-of-androgen-abuse-the-haarlem-/ (Accessed: 6 November 2026).
Hackett, G., Kirby, M., Edwards, D., Jones, T.H., Wylie, K., Ossei-Gerning, N., David, J. and Muneer, A. (2023) ‘The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice’, World Journal of Men’s Health, 41(3), pp. 508-537. Available at: https://pubmed.ncbi.nlm.nih.gov/36876744/ (Accessed: 6 November 2026).